Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 2/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 2/20 | 0.34 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | JAK2 | O60674 | 1/20 | 0.30 |
| ▸ | BTK | Q06187 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10015033 | 0.84 | LPL (0.44) | LPLLIPGEGFRJAK2BTK | |
| SCHEMBL20623676 | 0.77 | LPL (0.41) | LPLLIPGEGFRJAK2BTK | |
| SCHEMBL30428819 | 0.77 | LPL (0.41) | LPLLIPGEGFRJAK2BTK | |
| SCHEMBL2228172 | 0.76 | HPRT1 (0.45) | LPLLIPG | |
| SCHEMBL31357522 | 0.76 | HPRT1 (0.45) | LPLLIPG | |
| SCHEMBL24614226 | 0.75 | IDO1 (0.41) | — | |
| SCHEMBL734336 | 0.73 | LPL (0.45) | LPLLIPG | |
| SCHEMBL25165622 | 0.73 | NQO2 (0.40) | — | |
| SCHEMBL22433031 | 0.72 | LPL (0.40) | LPLLIPGEGFRJAK2BTK | |
| SCHEMBL31277382 | 0.72 | LPL (0.40) | LPLLIPGEGFRJAK2BTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8765270-B2 | Triazine compound and organic light emitting device using the same | CANON KABUSHIKI KAISHA (JP) | 2014-07-01 | — | — | US | disclosed |
| US-8765270-B2 | Triazine compound and organic light emitting device using the same | CANON KABUSHIKI KAISHA (JP) | 2014-07-01 | — | — | US | disclosed |
| US-20110240983-A1 | TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-10-06 | — | — | US | disclosed |
| US-20110240983-A1 | TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2011-10-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110240983-A1 | TRIAZINE COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME | TERT, CYP1A1, NR2E3 | LPL 3606/4885LIPG 4717/4885EGFR 4080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.